Danian Dai
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- Oncology top 10%
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer, Lipids, and Metabolism 4
- Breast Cancer Treatment Studies 3
- Oncology 16
- Lung Cancer Research Studies 4
- Cancer Immunotherapy and Biomarkers 3
- Cancer Cells and Metastasis 3
- Journals
- Journal of Cancer (5 papers)PLoS ONE (3 papers)Aging (2 papers)Cancer Biomarkers (1 paper)Cell Death and Disease (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Danian Dai
28 papers receiving 817 citations
Peers
Comparison fields: 5 of 74
- Cancer Research 398
- Oncology 295
- Molecular Biology 448
- Pulmonary and Respiratory Medicine 169
- Immunology 75
Countries citing papers authored by Danian Dai
This map shows the geographic impact of Danian Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danian Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danian Dai more than expected).
Fields of papers citing papers by Danian Dai
This network shows the impact of papers produced by Danian Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danian Dai. The network helps show where Danian Dai may publish in the future.
Co-authors
The 25 scholars most cited alongside Danian Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 42 | |
| 4 | 2024 | 7 | |
| 5 | 2023 | 3 | |
| 6 | 2022 | 6 | |
| 7 | 2021 | 11 | |
| 8 | 2020 | 9 | |
| 9 | 2020 | 10 | |
| 10 | 2019 | 16 | |
| 11 | 2018 | 49 | |
| 12 | 2018 | 7 | |
| 13 | 2018 | 212 | |
| 14 | 2017 | 18 | |
| 15 | 2017 | 29 | |
| 16 | 2017 | 51 | |
| 17 | 2016 | 38 | |
| 18 | 2016 | 25 | |
| 19 | 2016 | 16 | |
| 20 | 2016 | 26 |
About Danian Dai
Danian Dai is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Immunology, having authored 28 papers that have together received 823 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (6 papers), Cancer, Lipids, and Metabolism (4 papers), Lung Cancer Research Studies (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer Cells and Metastasis (3 papers), Breast Cancer Treatment Studies (3 papers), Advanced Breast Cancer Therapies (2 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Cancer Research (398 citations), Oncology (295 citations), Molecular Biology (448 citations), Pulmonary and Respiratory Medicine (169 citations) and Immunology (75 citations). Danian Dai has collaborated with scholars based in China and United States. Frequent co-authors include Hailin Tang, Weidong Wei, Xiaoming Xie, Xiaojia Huang, Bo Chen, Bo Chen, Lu Yang, Jin Wang, Xinhua Xie and Yanan Kong. Their work appears in journals such as Journal of Cancer, PLoS ONE, Aging, Cancer Biomarkers and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.